Select Journal or Resource JAMA & Archives Home JAMA Archives of   Dermatology   Facial Plastic Surgery   Family Medicine (1992-2000)   General Psychiatry   Internal Medicine   Neurology   Neurology and Psychiatry (1919-1959)   Ophthalmology   Otolaryngology—Head & Neck Surgery   Pediatrics & Adolescent Medicine   Surgery JAMA-français JAMA & Archives CME Calendar of Events JAMA Career Center For The Media JAMAevidence Peer Review Congress Student JAMA (1998-2004)

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In Vol. 3 No. 1, January 1994   Archives  •  Online Features Brief Reports  This Article  • Abstract  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal International Normalized Ratio The New Standard for Monitoring Oral Anticoagulation Julienne K. Kirk, PharmD; K. Patricia McGann, MD, MSPH Arch Fam Med. 1994;3(1):71-74. References Article references have been provided for searching and linking. Additional reference information may be available in the article PDF. 1. La Piana Simonsen L. What are pharmacists dispensing most often? Pharmacy Times. 1993:29-44. 2. Denniston PL. 1993 Physicians GenRx. Smithtown, NY: Data Pharmaceutica Inc; 1993:1-216. 3. Hirsch J, Levine M. Confusion over the therapeutic range for monitoring oral anticoagulant therapy in North America. Thromb Haemost. 1988;59:129-132. PUBMED 4. Ansell JE. Oral anticoagulation therapy: 50 years later. Arch Intern Med. 1993;153:586-596. FREE FULL TEXT 5. Hirsch J. Oral anticoagulant drugs. N Engl J Med. 1991;324:1865-1875. PUBMED 6. Hirsch J, Dalen JE, Deykin D, Poller L. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 1992;102(suppl_4):312-325. 7. Eckman MH, Levine HJ, Pauker SG. Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulation therapy. N Engl J Med. 1993;329:696-702. FREE FULL TEXT 8. Third ACCP Consensus Conference on Antithrombotic Therapy. Chest. 1992;102(4S):303-349. PUBMED 9. Nichols WL, Bowie EJ. Standardization of the prothrombin time for monitoring orally administered anticoagulant therapy with use of the international normalized ratio system. Mayo Clin Proc. 1993;68:897-898. PUBMED 10. Dade Determination of INR. Deerfield, III: Baxter Diagnostics Inc; 1991. Product literature. 11. Force RW, Roush MK, Bussey HI. Warfarin and the international normalized ratio. Ann Pharmacother. 1992:26:430-431. PUBMED 12. Poller L. A simple nomogram for the derivation of international normalised ratios for the standardisation of prothrombin time. Thromb Haemost. 1988;60:18-20. PUBMED 13. Ansell JE. Imprecision of prothrombin time monitoring of oral anticoagulants: a survey of hospital laboratories. Am J Clin Pathol. 1992;98:237-239. PUBMED 14. Bussey HI, Force RW, Bianco TM, Leonard AD. Reliance on prothrombin time ratios causes significant errors in anticoagulation therapy. Arch Intern Med. 1992;152:278-282. FREE FULL TEXT 15. Vanscoy GJ, Krause JR. Warfarin and the international normalized ratio: reducing interlaboratory effects. Ann Pharmacother. 1991;25:1190-1192. ABSTRACT 16. Gottfried EL, Valerie LN, Levin J, Corash L. Problems with the international normalized ratio. Blood. 1992:80:2690. PUBMED 17. Hirsch J. Substandard monitoring of warfarin in North America: time for a change. Arch Intern Med. 1992;152:257-258. FREE FULL TEXT 18. Gore JM, Dalen JE. Cardiovascular disease. JAMA. 1993;270:190-192. FREE FULL TEXT 19. Hirsch J. Use of warfarin (Coumarin). Heart Dis Stroke. 1993;2:209-216. PUBMED